// App-Quantinova.ai

1226-240 : OPTIMIZING P2Y12-RECEPTOR INHIBITION IN ACUTE CORONARY SYNDROME PATIENTS BASED ON PLATELET FUNCTION TESTING: IMPACT OF PRASUGREL AND HIGH-DOSE CLOPIDOGREL

Researchers

Presenter

  • Daniel Aradi

Principal Investigators

  • Adrienn Tornyos

  • Andras Komocsi

Medical Centers

  • Heart Institute, University of Pecs, Pecs, Hungary

  • Heart Center Balatonfured, Balatonfured, Hungary

Locations

  • Hungary

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Prasugrel

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved